Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9337 |
High Similarity |
NPD7074 |
Phase 3 |
0.9281 |
High Similarity |
NPD6797 |
Phase 2 |
0.9277 |
High Similarity |
NPD7054 |
Approved |
0.9226 |
High Similarity |
NPD7251 |
Discontinued |
0.9222 |
High Similarity |
NPD7472 |
Approved |
0.9172 |
High Similarity |
NPD7808 |
Phase 3 |
0.9172 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.9102 |
High Similarity |
NPD3818 |
Discontinued |
0.9096 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9096 |
High Similarity |
NPD6166 |
Phase 2 |
0.9096 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9048 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.9012 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8951 |
High Similarity |
NPD1934 |
Approved |
0.8848 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8675 |
High Similarity |
NPD3882 |
Suspended |
0.8667 |
High Similarity |
NPD2801 |
Approved |
0.8631 |
High Similarity |
NPD5494 |
Approved |
0.8623 |
High Similarity |
NPD7075 |
Discontinued |
0.8614 |
High Similarity |
NPD3817 |
Phase 2 |
0.8563 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8485 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8466 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8457 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8443 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8405 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.84 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8343 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8314 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8284 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8276 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8274 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8256 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8225 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8225 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8182 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8167 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8107 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8086 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8086 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.807 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8056 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8056 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8037 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8035 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8033 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8032 |
Intermediate Similarity |
NPD6777 |
Approved |
0.8032 |
Intermediate Similarity |
NPD6776 |
Approved |
0.8032 |
Intermediate Similarity |
NPD6781 |
Approved |
0.8032 |
Intermediate Similarity |
NPD6778 |
Approved |
0.8032 |
Intermediate Similarity |
NPD6782 |
Approved |
0.8032 |
Intermediate Similarity |
NPD6780 |
Approved |
0.8032 |
Intermediate Similarity |
NPD6779 |
Approved |
0.8023 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7955 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7944 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7941 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.791 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7906 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7906 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7906 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7906 |
Intermediate Similarity |
NPD7698 |
Approved |
0.787 |
Intermediate Similarity |
NPD5403 |
Approved |
0.787 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7849 |
Intermediate Similarity |
NPD37 |
Approved |
0.7841 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7841 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7835 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD919 |
Approved |
0.7824 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7816 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7816 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7816 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7805 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7795 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7772 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7772 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7766 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7766 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7751 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7744 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7737 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7737 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7716 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7714 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7701 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD7584 |
Approved |
0.767 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7665 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD7874 |
Approved |
0.765 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7647 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7647 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7647 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7626 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7607 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7607 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7607 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD943 |
Approved |
0.759 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.759 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7588 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7577 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7574 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7565 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7545 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.754 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7515 |
Intermediate Similarity |
NPD1607 |
Approved |
0.75 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7469 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7455 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7447 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7425 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7412 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7412 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7409 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7371 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7356 |
Intermediate Similarity |
NPD920 |
Approved |
0.7353 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7337 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.73 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7297 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7295 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7278 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7254 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7254 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.725 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7241 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7219 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7216 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7213 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7213 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7209 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7169 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7151 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7126 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7087 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7085 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7085 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7083 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7081 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7079 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.705 |
Intermediate Similarity |
NPD5006 |
Approved |
0.705 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7048 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7043 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7041 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.703 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7027 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7018 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD3452 |
Approved |
0.7 |
Intermediate Similarity |
NPD3450 |
Approved |
0.6994 |
Remote Similarity |
NPD2424 |
Discontinued |
0.698 |
Remote Similarity |
NPD4583 |
Approved |
0.698 |
Remote Similarity |
NPD4582 |
Approved |
0.6978 |
Remote Similarity |
NPD5353 |
Approved |
0.6973
|
Remote Similarity |
NPD8127 |
Discontinued |